BSX
NYSE
Health Care
$44.60
USD
-$0.54 (-1.20%)
At close: Jul 6, 2026, 4:00 PM EDT
Market Cap:
$65.73B
Volume:
17.1M
Previous Close
$45.14
Day Range
$43.84 - $45.30
52 Week Range
$42.43 - $109.50
Average Volume (10 Days)
25.4M
P/E Ratio
22.68
Dividend Yield
0.00%
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 59,000 full-time employees. The firm's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
CEO
Mr. Michael Mahoney
Headquaters
Marlborough, MASSACHUSETTS, US
Founded
1992
Employees
59,000
Boston Scientific invested $1.5 billion for a 34% stake in MiRus, securing exclusive rights to acquire the company's investigational SIEGEL TAVR valve system. The deal includes an option to purchase full ownership of the TAVR business for an additional $3 billion upon achieving clinical and regulatory milestones.
0
0
SYK
Stryker Corp
$324.73
-0.6%